Patent ID: 8735328

Claim:
A method for producing a fusion polypeptide capable of specifically binding simultaneously to at least two epitopes of a polypeptide antigen known to be variable, said epitopes consisting of 3 to 5 adjacent conserved amino acid residues of said antigen, the method comprising the steps of: a) selecting 3 to 5 amino acid long conserved regions in the antigen by computational analysis of known amino acid sequences of the antigen, wherein said antigen is the p24 polypeptide of HIV, and wherein said peptide is selected from the 3 to 5 amino acid long regions of the antigen and wherein the peptide is selected from the group consisting of: NAWVK (SEQ ID NO: 2), FRDY (SEQ ID NO: 3), RAEQ (SEQ ID NO: 4), NPDC (SEQ ID NO: 5), VGGP (SEQ ID NO: 6), AWVK (SEQ ID NO: 7), NAWV (SEQ ID NO: 8), RDY, FRD, AEQ, RAE, PDC, NPD, GGP, VGG, WVK, AWV, NAW, SDI, PVG, GLN, WMT, TLL, EMM, and HKA; b) preparing peptides selected is step a); c) contacting a library of particles expressing binding proteins with one or more of said peptides; d) isolating those particles which express binding proteins having binding activity towards the peptides; e) subjecting nucleic acid obtained or derived from the particle(s) isolated in step d) to mutagenesis; f) preparing a library of particles expressing binding proteins based on the particles obtained from step e); g) contacting a library obtained from step f) with one or more of said peptides or fragment thereof; h) isolating those particles which express binding proteins having improved binding activity towards said peptides or a fragment thereof; i) repeating steps e) to h) one or more times; j) obtaining particles which are able to specifically bind to an at least 3 to 5 adjacent amino acids long epitope in said antigen from the particles obtained from step i); k) preparing said fusion polypeptide based on the particles isolated in step j) by combining into one fusion polypeptide the binding specificity of two of said particles having specificity to at least two different epitopes of said antigen resulting in a fusion polypeptide having high specificity with regard to variants of said antigen.